Theranexus, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The Company's lead drug candidate includes THN102, which is in phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain.
|Size (employees)||10 (est)+400%|
When was Theranexus founded?
Theranexus was founded in 2013.
Who are Theranexus key executives?
Theranexus's key executives are Franck Mouthon, Mathieu Charveriat and Julien Veys.
How many employees does Theranexus have?
Theranexus has 10 employees.
Who are Theranexus competitors?
Competitors of Theranexus include Kiniksa Pharmaceuticals, Sartorius Stedim BioOutsource and Neurosearch.
Where is Theranexus headquarters?
Theranexus headquarters is located at 60 avenue Rockefeller, Lyon.
Where are Theranexus offices?
Theranexus has an office in Lyon.
How many offices does Theranexus have?
Theranexus has 1 office.